At a glance
- Originator Pfizer
- Class Antiretrovirals; Small molecules
- Mechanism of Action RNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV-1 infections
Most Recent Events
- 19 Oct 2000 Discontinued-Preclinical for HIV-1 infections in USA (Unknown route)
- 14 Jul 1998 No-Development-Reported for HIV-1 infections in USA (Unknown route)
- 21 Oct 1994 Preclinical development for HIV-1 infections in USA (Unknown route)